Addus HomeCare (NASDAQ:ADUS) Director Sells $23,250.00 in Stock

Addus HomeCare Corporation (NASDAQ:ADUS) Director Esteban Lopez sold 250 shares of the company’s stock in a transaction that occurred on Thursday, May 21st. The shares were sold at an average price of $93.00, for a total value of $23,250.00. Following the completion of the transaction, the director directly owned 3,200 shares of the company’s stock, valued at $297,600. This trade represents a 7.25% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which can be accessed through this link.

Esteban Lopez also recently made the following trade(s):

• On Tuesday, May 19th, Esteban Lopez sold 250 shares of Addus HomeCare stock. The shares were sold at an average price of $93.00, for a total value of $23,250.00.

Addus HomeCare Stock Performance

Shares of ADUS stock traded down $0.61 during trading hours on Friday, hitting $92.65. The stock had a trading volume of 166,366 shares, compared to its average volume of 246,282. The firm has a market capitalization of $1.73 billion, a PE ratio of 17.13, a PEG ratio of 1.29 and a beta of 0.92. Addus HomeCare Corporation has a twelve month low of $89.76 and a twelve month high of $124.43. The stock’s 50 day moving average is $95.93 and its 200 day moving average is $105.56. The company has a debt-to-equity ratio of 0.08, a current ratio of 1.83 and a quick ratio of 1.83.

Addus HomeCare (NASDAQ:ADUS) last posted its quarterly earnings data on Monday, May 4th. The company reported $1.62 earnings per share for the quarter, beating the consensus estimate of $1.52 by $0.10. The business had revenue of $363.50 million during the quarter, compared to the consensus estimate of $366.41 million. Addus HomeCare had a return on equity of 9.80% and a net margin of 6.89%.The company’s revenue was up 7.7% compared to the same quarter last year. During the same period in the prior year, the company earned $1.42 earnings per share. As a group, research analysts forecast that Addus HomeCare Corporation will post 6.24 earnings per share for the current fiscal year.

Institutional Investors Weigh In On Addus HomeCare

Several large investors have recently modified their holdings of the stock. TimesSquare Capital Management LLC increased its position in shares of Addus HomeCare by 6.2% in the third quarter. TimesSquare Capital Management LLC now owns 418,348 shares of the company’s stock valued at $49,361,000 after buying an additional 24,301 shares in the last quarter. Public Sector Pension Investment Board increased its position in shares of Addus HomeCare by 14.4% in the third quarter. Public Sector Pension Investment Board now owns 70,827 shares of the company’s stock valued at $8,357,000 after buying an additional 8,893 shares in the last quarter. Burney Co. purchased a new position in shares of Addus HomeCare in the fourth quarter valued at $1,841,000. Capital Research Global Investors increased its position in shares of Addus HomeCare by 9.0% in the third quarter. Capital Research Global Investors now owns 1,201,560 shares of the company’s stock valued at $141,772,000 after buying an additional 99,262 shares in the last quarter. Finally, Vanguard Group Inc. increased its position in shares of Addus HomeCare by 2.9% in the third quarter. Vanguard Group Inc. now owns 1,298,104 shares of the company’s stock valued at $153,163,000 after buying an additional 36,674 shares in the last quarter. Hedge funds and other institutional investors own 95.35% of the company’s stock.

Wall Street Analysts Forecast Growth

ADUS has been the subject of several research analyst reports. Barclays decreased their price objective on Addus HomeCare from $102.00 to $92.00 and set an “underweight” rating for the company in a report on Friday, May 15th. KeyCorp reissued an “overweight” rating on shares of Addus HomeCare in a report on Wednesday, February 25th. Citizens Jmp reissued a “market outperform” rating and issued a $142.00 price objective on shares of Addus HomeCare in a report on Monday. Stephens decreased their price objective on Addus HomeCare from $140.00 to $135.00 and set an “overweight” rating for the company in a report on Wednesday, February 25th. Finally, Wall Street Zen cut Addus HomeCare from a “strong-buy” rating to a “buy” rating in a research note on Saturday, March 21st. One investment analyst has rated the stock with a Strong Buy rating, seven have given a Buy rating, two have given a Hold rating and one has issued a Sell rating to the company. Based on data from MarketBeat, Addus HomeCare presently has a consensus rating of “Moderate Buy” and an average price target of $131.22.

About Addus HomeCare

Addus HomeCare (NASDAQ: ADUS) is a leading provider of home and community-based care services for elderly, disabled, and medically complex individuals across the United States. Through a network of company-owned and franchise locations, the company delivers a broad spectrum of non-medical personal care and licensed home health services designed to support clients’ independence and quality of life.

The company’s core offerings include personal care assistance—covering daily living activities, medication reminders, and light housekeeping—and skilled home health services delivered under the supervision of registered nurses and licensed therapists.